HW-CX04

N/A

Report date: 2025/01/26 15:33:25
NME

Base Information

Drug NameHW-CX04
Drug Alias NamePD-1 checkpoint inhibitor/PD-L1 checkpoint inhibitor (Nanjing Huawe Medicine Technology Group)HW-CX04
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProgrammed death-ligand 1 blockersProgrammed cell death protein 1 blockers
TargetsProgrammed cell death protein 1Programmed death-ligand 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNanjing Huawe Medicine Technology Group Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNanjing Huawe Medicine Technology Group Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A